What is the treatment for Erythema Ab Igne (Erythema Ab Ignis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Erythema Ab Igne

The primary and most critical treatment for erythema ab igne is immediate and complete cessation of heat exposure to the affected area. 1, 2, 3

First-Line Management: Heat Source Removal

  • Immediately discontinue all contact with the causative heat source (heating pads, space heaters, laptop computers, hot water bottles, heated car seats, or any infrared radiation source). 1, 2
  • Counsel patients extensively on the importance of permanently stopping prolonged heat exposure, as this is the only effective measure to prevent progression. 2
  • Early removal of the heat source typically results in progressive clearing over 8 weeks, though complete remission may not occur. 2
  • Delayed diagnosis and continued heat exposure can result in permanent hyperpigmentation or malignant transformation to squamous cell carcinoma, Merkel cell carcinoma, or basal cell carcinoma. 1, 3, 4

Prognosis and Expected Outcomes

  • With prompt heat source removal, prognosis is good and complete remission is possible in early cases. 3
  • In two-thirds of cases, skin changes progressively clear but may not completely resolve. 2
  • Patients who continue heat exposure will have persistent skin changes that may become permanent. 2
  • Chronic cases with established cutaneous atrophy and hyperpigmentation may never fully resolve even after heat source removal. 3

Management of Chronic or Premalignant Cases

For patients with chronic erythema ab igne showing epithelial dysplasia or carcinoma in situ, additional topical treatments are necessary:

  • Topical 5-fluorouracil cream has shown good response in individual case reports of established epithelial dysplasia. 5, 3
  • Topical imiquimod is an alternative option for premalignant changes. 5
  • Photodynamic therapy has achieved successful results in cases with carcinoma in situ. 5
  • Topical retinoids may be considered for chronic cases with premalignant cutaneous dysplasia. 3
  • Laser treatments are an option for persistent pigmentary changes. 3

Surveillance Requirements

  • All patients with permanent skin changes require ongoing monitoring due to the accepted precancerous nature of chronic erythema ab igne. 2, 4
  • Biopsy is indicated when malignancy is suspected, particularly if there are histologic features of squamous atypia with basal layer crowding and loss of maturation throughout the epidermis. 1, 4
  • Watch specifically for development of squamous cell carcinoma, Merkel cell carcinoma, or cutaneous marginal zone B cell lymphoma in longstanding cases. 3, 4

Common Pitfalls to Avoid

  • Do not delay counseling about heat source removal—this is the definitive treatment and delays result in permanent changes or malignancy. 1, 2
  • Do not assume patients will spontaneously stop the causative behavior; patients with eating disorders (a common population affected) may have increased pain thresholds and continue heat exposure despite skin changes. 2
  • Do not dismiss localized erythema ab igne over areas of pain (abdomen, lower back) as purely cosmetic—this can indicate underlying disorders including cancer. 3
  • Do not provide false reassurance about complete resolution—inform patients that chronic cases may result in permanent pigmentation. 2, 3

References

Research

[Three cases of erythma ab igne (EAI) in patients with eating disorders].

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2010

Research

Erythema ab igne: new technology rebounding upon its users?

International journal of dermatology, 2018

Research

[Treatment of carcinoma in situ of erythema ab igne with photodynamic therapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.